Related by context. Frequent words. (Click for all words.) 59 label dose escalation 59 Phase 2a trial 59 multicenter clinical 58 phase IIb 58 Phase 2b clinical 57 randomized Phase III 57 placebo controlled randomized 57 Phase III randomized 57 Phase 2b study 57 Phase III clinical 57 Phase 1b clinical 57 Phase IIb clinical 56 phase IIa 56 Phase 2a clinical 56 Phase III pivotal 56 multicenter 56 Phase IIa clinical 56 confirmatory Phase 3 56 Phase Ib 55 clinical trial 55 Phase 1b trial 55 multicenter randomized 55 Phase Ia 55 randomized controlled clinical 54 randomized clinical 54 Phase IIa trial 54 phase 2a 54 rNAPc2 54 relapsed multiple myeloma 54 pivotal Phase III 53 Phase IIb trial 53 Phase 2b 53 tesmilifene 53 Phase 1b 53 prospective observational 53 prospective randomized controlled 53 dose escalation trial 53 Phase 2b trial 53 prospective randomized 52 Neuradiab 52 Phase IIa 52 randomized Phase 52 safety tolerability pharmacokinetics 52 Investigational Device Exemption IDE 52 Phase III 51 multicentre 51 confirmatory Phase III 51 SUTENT 51 randomized controlled 51 dose cohorts 51 blind randomized placebo 51 Viprinex 51 DSMB 51 Phase IIb 51 acute ischemic stroke 51 teduglutide 51 sapacitabine 50 unblinded 50 pivotal Phase 50 ATTRACT 50 Phase III clinical trials 50 denufosol 50 pharmacodynamics 50 blinded placebo controlled 50 eculizumab 50 blinatumomab 50 ZYBRESTAT 50 PROPEL trial 50 multicenter study 50 multicenter randomized double 49 active comparator 49 LymphoStat B 49 IMC A# 49 Board DSMB 49 SPIRIT III 49 MOZOBIL 49 Phase 2a 49 secondary efficacy endpoints 49 blind randomized controlled 49 CYT# 49 PFO closure 49 RTOG 49 Phase 1a 49 randomized placebo controlled 48 PROMACTA 48 GVAX 48 PXD# 48 elesclomol 48 BAY #-# 48 axitinib 48 HGS ETR1 48 darapladib 48 FOLOTYN 48 aflibercept 48 dose escalation 48 eniluracil 48 clinical 48 talactoferrin 48 CA4P 48 randomized double 48 clinical trials